Twist Bioscience Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.8% | +5.3% | +8.2% | +4.0% | +4.7% | +4.6% | +3.5% | +3.1% | +4.7% | +6.8% | +6.9% | – | |
| – | +0.3% | +4.4% | +4.0% | +0.6% | -1.3% | +1.9% | -4.3% | +7.6% | +3.2% | +7.8% | +4.3% | – | |
| – | +18.1% | +6.6% | +14.2% | +8.4% | +12.0% | +7.4% | +11.4% | -0.9% | +6.2% | +5.8% | +9.3% | – | |
| – | -2.7% | +4.5% | -7.0% | -5.9% | +0.8% | +12.2% | -24.5% | -5.7% | +0.7% | +15.0% | -8.5% | – | |
| – | +18.8% | +5.3% | +2.1% | -6.4% | +5.7% | +13.3% | -0.5% | -10.4% | +23.2% | +8.8% | +6.1% | – | |
| – | +1.7% | +5.0% | +55.7% | -40.2% | +4.3% | +13.0% | -7.0% | -0.8% | +7.6% | +10.3% | +3.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | -17.2% | +495.8% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -230.6% | – | – | – | – | |
| – | – | +187.5% | -44.6% | -150.3% | – | +80.4% | +9.1% | +34.0% | -1.2% | -83.0% | -823.3% | – | |
| – | – | – | – | – | – | – | – | -233.1% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -179.1% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.